Clinical Trial Update: L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating L-asparaginase as a monotherapy salvage treatment for extranodal natural killer/T-cell lymphoma (NK/T-cell lymphoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Drugs mentioned

• L-asparaginase (L-asparaginase)

Snippet

Sponsor: Fudan University | Conditions: Lymphoma | Phase 2 | Status: COMPLETED